Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Reminder of obligations with respect to the advertising and sale of drugs (October 6, 2006) Unit Name: Drug Compliance Verification and Investigation Unit Telephone: 613-941-3967 Fax: 613-952-9805 Email: DCVIU_UVCEM@hc-sc.gc.ca (PDF Version - 21 K) Ce document est aussi…
ARCHIVED - Frequently Asked Questions - Compliance Inspections We have archived this page and will not be updating it. You can use it for research or reference. We have archived this page and will not be updating it. You can use it for research or reference. (November 16, 2004)…
ARCHIVED - Fact Sheet - Compliance Inspections of Canadian Pharmacy Sites Selling Prescription Drugs Via the Internet or Other Forms of Distance Dispensing We have archived this page and will not be updating it. You can use it for research or reference. We have archived this page…
Cover Letter - Guidance for Pre-manufacturing and Pre-exportation Notifications (C.07.011) under Canada's Access to Medicines Regime: Guide-0072 (December 1 st , 2007) Unit Name: Drug GMP Inspection Unit Telephone: 613-957-1492 Fax: 613-957-6709 Email:…
Inspection Strategy for Canada's Access to Medicines Regime (POLICY-0055) December 1, 2007 Supersedes: New document Date issued: August 2007 Date of implementation: September 2007 Unit Name: Drug GMP Inspection Unit Telephone: 613-957-1492 Fax: 613-957-6709 Email:…
Notice to Stakeholders - Good Manufacturing Practices for Active Pharmaceutical Ingredients - Implementation Pilot Project for Selected Consumer Health Products November 2013 The Health Products and Food Branch Inspectorate is notifying stakeholders of a pilot project concerning…
ARCHIVED Notice to Stakeholders - Amended Food and Drug Regulations for Active Ingredients - Coming into force on November 8, 2013 Contact Information Active pharmaceutical ingredients (API): API_questions_IPA@hc-sc.gc.ca Drug establishment licences (DEL):…
ARCHIVED Notice to Stakeholders - Establishment Licence Application deadline - February 8, 2014 Contact Information New Regulatory Requirements This is to remind regulated parties that the transition period that was established for regulated parties to comply with the new…
Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients This notice has previously undergone consultation. For more information visit Consultation Summary: Notice to Stakeholders - Implementation of…
ARCHIVED Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients for Veterinary Use We have archived this page and will not be updating it. View the latest available version . We have archived this page and…
Early release: coverage is bounded to the current corpus, and features may change.
